Edith M. Heintjes

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Characterisation of a clinical trial-like population of high cardiovascular risk patients prior to myocardial infarction or stroke in the real world: design and protocol for a multidatabase retrospective cohort study.

Characterisation of a clinical trial-like population of high cardiovascular risk patients prior to myocardial infarction or stroke in the real world: design and protocol for a multidatabase retrospective cohort study.

Journal: BMJ open

Published: July 30, 2025

Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the Netherlands.

Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the Netherlands.

Journal: Current medical research and opinion

Published: September 28, 2022

Non-cardiovascular medication and readmission for heart failure: an observational cohort study.

Non-cardiovascular medication and readmission for heart failure: an observational cohort study.

Journal: International journal of clinical pharmacy

Published: October 31, 2021

Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases.

Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases.

Journal: PloS one

Published: August 24, 2020

Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries.

Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries.

Journal: Clinical epidemiology

Published: December 19, 2019

Trends in mortality, cardiovascular complications, and risk factors in type 2 diabetes.

Trends in mortality, cardiovascular complications, and risk factors in type 2 diabetes.

Journal: The Netherlands journal of medicine

Published: December 10, 2019

Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.

Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.

Journal: Heart failure reviews

Published: March 09, 2019

Clinical effectiveness of liraglutide vs basal insulin in a real-world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes.

Clinical effectiveness of liraglutide vs basal insulin in a real-world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes.

Journal: Diabetes, obesity & metabolism

Published: February 06, 2018

Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study.

Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study.

Journal: BMJ open diabetes research & care

Published: October 04, 2017

Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries.

Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries.

Journal: Clinical therapeutics

Published: July 20, 2017

Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study.

Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: June 23, 2017

Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study.

Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study.

Journal: Clinical therapeutics

Published: December 15, 2016

Showing 1-12 of 29

Last Updated: 09/26/2026